Neurogene NGNE
NASDAQ NGNE
$25.28 -0.72 (-2.77%)
At close: Nov 10, 2026 · 4:00 PM EST

Neurogene (NGNE) Net Long-Term Debt Issued (Repaid) (2014 - 2026)

Updated

Neurogene (NGNE) reported Non-Current Debt of -$2.6 million for FY2014, compared with $2.39 million in FY2013.

Analysis

Neurogene (NGNE) Net Long-Term Debt Issued (Repaid) (2014 - 2026) Analysis & Trends

  • According to Business Quant data, Non-Current Debt came in at $2.39 million in FY2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net LT Debt (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn -1.00 Mn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 9.98 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn -
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -3.05 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn -19.00 Mn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 Neurogene 577.56 Mn -425.44 Mn - -5,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -5,000.00
Mar 31, 2026 -6,000.00
Dec 31, 2025 -19,000.00
Sep 30, 2025 -13,000.00
Jun 30, 2025 -14,000.00
Mar 31, 2025 -15,000.00
Dec 31, 2024 -13,000.00
Sep 30, 2024 -12,000.00
Jun 30, 2024 -16,000.00
Mar 31, 2024 -11,000.00
Dec 31, 2023 -8,000.00
Sep 30, 2023 -10,000.00
Jun 30, 2023 -6,000.00
Mar 31, 2023 -5,000.00
Dec 31, 2022 53,000.00
Sep 30, 2022 -52,000.00
Jun 30, 2022 -1,000.00
Mar 31, 2022 -1,000.00
Dec 31, 2021 -49,000.00
Jun 30, 2021 -2,000.00
API Access

Neurogene Net Long-Term Debt Issued (Repaid) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=NGNE&period=max&api_key=YOUR_API_KEY